ATE553105T1 - Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer - Google Patents
Azetidin-analoge ais nucleosidase- und phosphorylase-hemmerInfo
- Publication number
- ATE553105T1 ATE553105T1 AT07866894T AT07866894T ATE553105T1 AT E553105 T1 ATE553105 T1 AT E553105T1 AT 07866894 T AT07866894 T AT 07866894T AT 07866894 T AT07866894 T AT 07866894T AT E553105 T1 ATE553105 T1 AT E553105T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleosidase
- compounds
- ais
- phosphorylase inhibitors
- azetidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87694706P | 2006-12-22 | 2006-12-22 | |
PCT/NZ2007/000387 WO2008079028A1 (en) | 2006-12-22 | 2007-12-21 | Azetidine analogues of nucleosidase and phosphorylase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE553105T1 true ATE553105T1 (de) | 2012-04-15 |
Family
ID=39562725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07866894T ATE553105T1 (de) | 2006-12-22 | 2007-12-21 | Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer |
Country Status (15)
Country | Link |
---|---|
US (1) | US8283345B2 (de) |
EP (1) | EP2114925B8 (de) |
JP (1) | JP2010513477A (de) |
KR (1) | KR20090101278A (de) |
CN (1) | CN101600711A (de) |
AT (1) | ATE553105T1 (de) |
AU (1) | AU2007338953A1 (de) |
CA (1) | CA2674525A1 (de) |
CY (1) | CY1112889T1 (de) |
DK (1) | DK2114925T3 (de) |
ES (1) | ES2385759T3 (de) |
HK (1) | HK1138276A1 (de) |
NZ (1) | NZ577682A (de) |
PT (1) | PT2114925E (de) |
WO (1) | WO2008079028A1 (de) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2330042C2 (ru) * | 2002-08-21 | 2008-07-27 | Альберт Эйнштейн Колледж Оф Медсин Оф Йешива Юниверсити | Ингибиторы нуклеозидфосфорилаз и нуклеозидаз |
NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
NZ533360A (en) | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
WO2006068760A2 (en) | 2004-11-19 | 2006-06-29 | The Regents Of The University Of California | Anti-inflammatory pyrazolopyrimidines |
EP1924684A4 (de) | 2005-07-27 | 2009-02-11 | Einstein Coll Med | Übergangszustandsstruktur von 5'-methylthioadenosin/s-adenosylhomocystein-nukleosidasen |
NZ544187A (en) * | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
WO2007097643A1 (en) * | 2006-02-22 | 2007-08-30 | Industrial Research Limited | Analogues of coformycin and their use for treating protozoan parasite infections |
US8916571B2 (en) | 2006-02-24 | 2014-12-23 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase |
AU2007218334A1 (en) * | 2006-02-24 | 2007-08-30 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases |
WO2008127226A2 (en) | 2006-04-04 | 2008-10-23 | The Regents Of The University Of California | P13 kinase antagonists |
AU2007293774C1 (en) | 2006-09-07 | 2014-12-18 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
US8383636B2 (en) * | 2006-09-07 | 2013-02-26 | Industrial Research Limited | Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase |
WO2009046448A1 (en) | 2007-10-04 | 2009-04-09 | Intellikine, Inc. | Chemical entities and therapeutic uses thereof |
KR101897881B1 (ko) | 2008-01-04 | 2018-09-12 | 인텔리카인, 엘엘씨 | 특정 화학 물질, 조성물 및 방법 |
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
US8993580B2 (en) | 2008-03-14 | 2015-03-31 | Intellikine Llc | Benzothiazole kinase inhibitors and methods of use |
JP5547099B2 (ja) | 2008-03-14 | 2014-07-09 | インテリカイン, エルエルシー | キナーゼ阻害剤および使用方法 |
US20110224223A1 (en) | 2008-07-08 | 2011-09-15 | The Regents Of The University Of California, A California Corporation | MTOR Modulators and Uses Thereof |
CN102124009B (zh) | 2008-07-08 | 2014-07-23 | 因特利凯公司 | 激酶抑制剂及其使用方法 |
US20110190265A1 (en) * | 2008-09-22 | 2011-08-04 | Schramm Vern L | Methods and compositions for treating bacterial infections by inhibiting quorum sensing |
JP5731978B2 (ja) | 2008-09-26 | 2015-06-10 | インテリカイン, エルエルシー | 複素環キナーゼ阻害剤 |
US8697709B2 (en) | 2008-10-16 | 2014-04-15 | The Regents Of The University Of California | Fused ring heteroaryl kinase inhibitors |
US8476282B2 (en) | 2008-11-03 | 2013-07-02 | Intellikine Llc | Benzoxazole kinase inhibitors and methods of use |
GB0904287D0 (en) | 2009-03-12 | 2009-04-22 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
CA2760791C (en) | 2009-05-07 | 2017-06-20 | Intellikine, Inc. | Heterocyclic compounds and uses thereof |
CA2768291C (en) | 2009-07-17 | 2018-03-27 | Albert Einstein College Of Medicine Of Yeshiva University | 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
WO2011047384A2 (en) | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Methods of inhibiting ire1 |
WO2011146882A1 (en) | 2010-05-21 | 2011-11-24 | Intellikine, Inc. | Chemical compounds, compositions and methods for kinase modulation |
CA2817577A1 (en) | 2010-11-10 | 2012-05-18 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
WO2012074912A1 (en) | 2010-11-29 | 2012-06-07 | Albert Einstein College Of Medicine Of Yeshiva University | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase |
KR101875720B1 (ko) | 2011-01-10 | 2018-07-09 | 인피니티 파마슈티칼스, 인코포레이티드 | 이소퀴놀린온 및 이의 고체 형태의 제조 방법 |
CN106619647A (zh) | 2011-02-23 | 2017-05-10 | 因特利凯有限责任公司 | 激酶抑制剂的组合及其用途 |
WO2012150866A1 (en) * | 2011-05-03 | 2012-11-08 | Industrial Research Limited | Phosphoribosyltransferase inhibitors and uses thereof |
KR20140063605A (ko) | 2011-07-19 | 2014-05-27 | 인피니티 파마슈티칼스, 인코포레이티드 | 헤테로사이클릭 화합물 및 그의 용도 |
JP6027610B2 (ja) | 2011-07-19 | 2016-11-16 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | 複素環式化合物及びその使用 |
AR091790A1 (es) | 2011-08-29 | 2015-03-04 | Infinity Pharmaceuticals Inc | Derivados de isoquinolin-1-ona y sus usos |
MX370814B (es) | 2011-09-02 | 2020-01-08 | Univ California | Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas. |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
US11186575B2 (en) | 2012-08-07 | 2021-11-30 | Alber Einslein College of Medicine | Treatment of helicobacter pylori infections |
EP2900673A4 (de) | 2012-09-26 | 2016-10-19 | Univ California | Ire1-modulation |
US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
US9616129B2 (en) | 2013-06-22 | 2017-04-11 | Nitor Therapeutics | Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency |
US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
EP3052485B1 (de) | 2013-10-04 | 2021-07-28 | Infinity Pharmaceuticals, Inc. | Heterocyclische verbindungen und verwendungen davon |
BR112016014760A2 (pt) | 2013-12-24 | 2017-12-12 | Harvard College | composto, composição farmacêutica, métodos para tratamento de uma condição, para inibir e validar atividade de cinase, para modular o trajeto de b-catenina e o trajeto de tgfb/bmp em uma célula, para modular a atividade de stat1 e de hif-1-alfa em uma célula, para aumentar a expressão de bim e para preparar um composto, mutante, e, proteína |
WO2015123101A1 (en) | 2014-02-12 | 2015-08-20 | Albert Einstein College Of Medicine Of Yeshiva University | Treatment of h. pylori infections using mtan inhibitors |
EP4066834A1 (de) | 2014-03-19 | 2022-10-05 | Infinity Pharmaceuticals, Inc. | Heterocyclische verbindungen zur verwendung in der behandlung von pi3k-gamma-vermittelten erkrankungen |
US20150320755A1 (en) | 2014-04-16 | 2015-11-12 | Infinity Pharmaceuticals, Inc. | Combination therapies |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
EP3294298A4 (de) | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin-analoga, synthese und verwendungen |
WO2017004411A1 (en) | 2015-07-01 | 2017-01-05 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses and uses thereof |
EP3350183A1 (de) | 2015-09-14 | 2018-07-25 | Infinity Pharmaceuticals, Inc. | Feste formen von isochinolinonderivaten, herstellungsverfahren, zusammensetzungen damit und verwendungsverfahren dafür |
CN109415382A (zh) * | 2016-02-19 | 2019-03-01 | 哈佛学院院长等 | 皮质抑素类似物 |
US10759806B2 (en) | 2016-03-17 | 2020-09-01 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors |
US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
CN109640999A (zh) | 2016-06-24 | 2019-04-16 | 无限药品股份有限公司 | 组合疗法 |
CA3034705C (en) | 2016-08-31 | 2021-08-03 | Agios Pharmaceuticals, Inc. | Inhibitors of cellular metabolic processes |
CN108069889B (zh) * | 2016-11-10 | 2021-10-01 | 上海西浦医药科技有限公司 | 一种氮杂环丁烷-3-甲酸的合成方法 |
WO2021133915A1 (en) * | 2019-12-23 | 2021-07-01 | Sanford Burnham Prebys Medical Discovery Institute | Ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) modulators and uses thereof |
CN116478172B (zh) * | 2023-06-20 | 2023-09-05 | 英矽智能科技(上海)有限公司 | 吡咯并[3,2-d]嘧啶类化合物及其应用 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6379911B2 (en) | 1996-02-23 | 2002-04-30 | Albert Einstein College Of Medicine Of Yeshiva University | Enzyme detection/assay method and substrates |
GB9609374D0 (en) | 1996-05-03 | 1996-07-10 | Merck Sharp & Dohme | Therapeutic agents |
US5985848A (en) | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
NZ506465A (en) * | 1998-02-26 | 2003-08-29 | Akzo Nobel Nv | Derivatives of azetidine and pyrrolidine |
CN1196704C (zh) | 1999-04-08 | 2005-04-13 | 工业研究有限公司 | 制备核苷代谢抑制剂的方法及中间体化合物 |
US6448799B1 (en) * | 1999-09-30 | 2002-09-10 | Hitachi Electronics Engineering Co., Ltd. | Timing adjustment method and apparatus for semiconductor IC tester |
WO2002018371A1 (en) | 2000-08-29 | 2002-03-07 | Industrial Research Limited | Nucleoside metabolism inhibitors |
US6458799B1 (en) | 2000-08-31 | 2002-10-01 | Biocryst Pharmaceuticals, Inc. | Deazaguanine analog, preparation thereof and use thereof |
US7098334B2 (en) | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
RU2330042C2 (ru) | 2002-08-21 | 2008-07-27 | Альберт Эйнштейн Колледж Оф Медсин Оф Йешива Юниверсити | Ингибиторы нуклеозидфосфорилаз и нуклеозидаз |
JP2006511552A (ja) | 2002-12-13 | 2006-04-06 | スミスクライン ビーチャム コーポレーション | Ccr5拮抗薬としてのピロリジンおよびアゼチジン化合物 |
NZ523970A (en) | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
WO2005026131A1 (en) | 2003-09-05 | 2005-03-24 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state structure and inhibitors of thymidine phosphorylases |
NZ533360A (en) | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
AU2005269541A1 (en) | 2004-07-27 | 2006-02-09 | Biocryst Pharmaceuticals, Inc. | Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
NZ540160A (en) | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
EP1924684A4 (de) | 2005-07-27 | 2009-02-11 | Einstein Coll Med | Übergangszustandsstruktur von 5'-methylthioadenosin/s-adenosylhomocystein-nukleosidasen |
NZ544187A (en) | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
US8916571B2 (en) | 2006-02-24 | 2014-12-23 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase |
AU2007218334A1 (en) | 2006-02-24 | 2007-08-30 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases |
AU2007293774C1 (en) | 2006-09-07 | 2014-12-18 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
US8383636B2 (en) | 2006-09-07 | 2013-02-26 | Industrial Research Limited | Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase |
WO2008039324A1 (en) | 2006-09-26 | 2008-04-03 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state structure of human 5'-methylthioadenosine phosphorylase |
WO2009082247A1 (en) | 2007-12-21 | 2009-07-02 | Industrial Research Limited | Process for preparing immucillins having a methylene link |
US20110190265A1 (en) | 2008-09-22 | 2011-08-04 | Schramm Vern L | Methods and compositions for treating bacterial infections by inhibiting quorum sensing |
CA2768291C (en) | 2009-07-17 | 2018-03-27 | Albert Einstein College Of Medicine Of Yeshiva University | 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
-
2007
- 2007-12-21 CN CNA2007800478632A patent/CN101600711A/zh active Pending
- 2007-12-21 WO PCT/NZ2007/000387 patent/WO2008079028A1/en active Application Filing
- 2007-12-21 US US12/448,397 patent/US8283345B2/en not_active Expired - Fee Related
- 2007-12-21 PT PT07866894T patent/PT2114925E/pt unknown
- 2007-12-21 KR KR1020097015412A patent/KR20090101278A/ko not_active Application Discontinuation
- 2007-12-21 AU AU2007338953A patent/AU2007338953A1/en not_active Abandoned
- 2007-12-21 NZ NZ577682A patent/NZ577682A/en not_active IP Right Cessation
- 2007-12-21 JP JP2009542692A patent/JP2010513477A/ja active Pending
- 2007-12-21 CA CA002674525A patent/CA2674525A1/en not_active Abandoned
- 2007-12-21 AT AT07866894T patent/ATE553105T1/de active
- 2007-12-21 DK DK07866894.4T patent/DK2114925T3/da active
- 2007-12-21 ES ES07866894T patent/ES2385759T3/es active Active
- 2007-12-21 EP EP07866894.4A patent/EP2114925B8/de not_active Not-in-force
-
2010
- 2010-05-10 HK HK10104504.9A patent/HK1138276A1/xx not_active IP Right Cessation
-
2012
- 2012-07-04 CY CY20121100596T patent/CY1112889T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007338953A1 (en) | 2008-07-03 |
PT2114925E (pt) | 2012-05-29 |
DK2114925T3 (da) | 2012-05-29 |
EP2114925B1 (de) | 2012-04-11 |
EP2114925B8 (de) | 2013-04-10 |
EP2114925A4 (de) | 2010-10-20 |
CA2674525A1 (en) | 2008-07-03 |
US20100168141A1 (en) | 2010-07-01 |
US8283345B2 (en) | 2012-10-09 |
NZ577682A (en) | 2012-03-30 |
CY1112889T1 (el) | 2016-04-13 |
EP2114925A1 (de) | 2009-11-11 |
HK1138276A1 (en) | 2010-08-20 |
WO2008079028A1 (en) | 2008-07-03 |
KR20090101278A (ko) | 2009-09-24 |
JP2010513477A (ja) | 2010-04-30 |
ES2385759T3 (es) | 2012-07-31 |
CN101600711A (zh) | 2009-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE553105T1 (de) | Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer | |
EA200901138A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
HK1123733A1 (en) | Viral hepatitis treatment | |
CL2008000670A1 (es) | Compuestos derivados de tiazolidindionas y oxazolidindionas sustituidas; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, epoc, cancer, entre otras. | |
PH12014500053A1 (en) | Proteasome inhibitors | |
BRPI0915084B8 (pt) | composto, e, composição farmacêutica | |
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
TW200716646A (en) | (S)-N-methylnaltrexone | |
NO20092637L (no) | Fremgangsmater for behandling | |
NO20083501L (no) | Azaindoler som er anvendelige som inhibitorer for Janus-kinaser | |
NO20074823L (no) | Rasagilin-formuleringer med forbedret innholdsensartethet | |
EA200901133A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
CL2007003774A1 (es) | Compuestos derivados de quinazolina sustituidos, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, aterosclerosis y artritis. | |
MX2009009591A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
TW200611904A (en) | Aza-bicyclononanes | |
TW200606162A (en) | Pyrazolopyridine derivatives | |
TW200738659A (en) | Novel compounds | |
NO20090157L (no) | Tienpyrimidiner anvendelige som modulatorer av ionekanaler | |
NO341679B1 (no) | Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren | |
TW200730518A (en) | Crystalline forms of docetaxel and processes for their preparation | |
ATE441646T1 (de) | 5-ht4-rezeptoragonistenverbindungen | |
TW200724537A (en) | Pyrimidine derivatives for treatment of hyperproliferative disorders | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
DE602007010764D1 (en) | Benzamidglucokinaseaktivatoren | |
ATE431824T1 (de) | Chinolinon-carboxamid-verbindungen |